Theses/Dissertations from 2020
Characterization and Engineering of Interrupted Adenylation Domains, Taylor A. Lundy
Meaningful Measurement Matters: Defining Potentially Inappropriate Medication Use to Target Cognitive Outcomes, Ashley I. Martinez
ANTIRESORPTIVE BONE THERAPY USE IN ADVANCED LUNG CANCER AND ASSOCIATED OUTCOMES, Noor Naffakh
Theses/Dissertations from 2019
DEVELOPMENT OF MITHRAMYCIN ANALOGUES WITH IMPROVED EFFICACY AND REDUCED TOXICITY FOR TREATMENT OF ETS-DEPENDENT TUMORS IN EWING SARCOMA AND PROSTATE CANCER, Joseph Michael Eckenrode
MECHANISMS AND THERMODYNAMICS OF THE INFLUENCE OF SOLUTION-STATE INTERACTIONS BETWEEN HPMC AND SURFACTANTS ON MIXED ADSORPTION ONTO MODEL NANOPARTICLES, Salin Gupta Patel
DEVELOPING A WORKFLOW TO EVALUATE MEDICATIONS FOR REPURPOSING USING HEALTH CLAIMS DATA: APPLICATION TO SUBSTANCE USE DISORDERS, Emily Ruth Hankosky
TOWARD AN ENZYME-COUPLED, BIOORTHOGONAL PLATFORM FOR METHYLTRANSFERASES: PROBING THE SPECIFICITY OF METHIONINE ADENOSYLTRANSFERASES, Tyler D. Huber
CARBAPENEM-RESISTANT ENTEROBACTERIACEAE: EPIDEMIOLOGY, GENETICS, IN VITRO ACTIVITY, AND PHARMACODYNAMIC MODELING, Brandon Kulengowski
INVESTIGATION OF FACTORS INFLUENCING PROTEIN STABILITY IN LYOPHILIZED FORMULATIONS USING SOLID-STATE NMR SPECTROSCOPY, Ashley Lay-Fortenbery
THE DEVELOPMENT OF NOVEL PROTEASOME INHIBITORS FOR THE TREATMENT OF MULTIPLE MYELOMA AND ALZHEIMER’S DISEASE, Min Jae Lee
DISCOVERY OF NOVEL PHARMACOTHERAPEUTICS FOR SUBSTANCE USE DISORDERS, Na-Ra Lee
ACTINOMYCIN FAMILIAL DIVERSITY DRIVEN BY PHENOXAZINONE-CORE REACTIVITY, Matthew Richard McErlean
PHASE BEHAVIOR OF AMORPHOUS SOLID DISPERSIONS: MISCIBILITY AND MOLECULAR INTERACTIONS, Kanika Sarpal
Trends and Patterns in Use of Medications for Opioid Use Disorder in a Commercially Insured Population in the U.S., Catherine Serratore
THERAPEUTIC VIDEO GAMES AND THE SIMULATION OF EXECUTIVE FUNCTION DEFICITS IN ADHD, Markus Tiitto
Theses/Dissertations from 2018
DISCOVERY OF NOVEL MURAYMYCIN ANTIBIOTICS AND INSIGHT INTO THE BIOSYNTHETIC PATHWAY, Zheng Cui
USING THE QBEST EQUATION TO EVALUATE ELLAGIC ACID SAFETY DATA: GENERATING A QNOAEL WITH CONFIDENCE LEVELS FROM DISPARATE LITERATURE, Cynthia Rose Dickerson
EXPLORING THE EFFECT OF CHRONIC INFLAMMATION ON RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER, Sherif M. El-Refai
DISCOVERY OF NEW ANTIMICROBIAL OPTIONS AND EVALUATION OF AMINOGLYCOSIDE RESISTANCE ENZYME-ASSOCIATED RESISTANCE EPIDEMIC, Selina Y. L. Holbrook
CHARACTERIZATION AND ENGINEERING OF HUMAN PROTEINS AS THERAPEUTIC CANDIDATES, Kyungbo Kim